Real world outcomes of sequential ADC therapy in metastatic breast cancer: Patients treated with sacituzumab govitecan and trastuzumab deruxtecan

被引：0
|
作者：
Mai, Nicholas
Klar, Miriam
Ferraro, Emanuela
Bromberg, Maria
Chen, Yuan
Razavi, Pedram
Modi, Shanu
Chandarlapaty, Sarat
Walsh, Elaine M.
Drago, Joshua Z.
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA
[3] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1085
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Real World Data with Off-Label Insurance Approval of Trastuzumab Deruxtecan in Metastatic Breast Cancer
    Bobolts, Laura R.
    Mangurian, Mark
    Marur, Shanthi
    Wise, Corey
    Pozotrigo, Melissa
    Solomon, Hiywete
    Hartung, Nicole
    Ravindranathan, Meera
    Makielski, Rory
    Marur, Shika
    Toler, Andrew
    CANCER RESEARCH, 2023, 83 (05)
  • [22] Sacituzumab govitecan versus chemotherapy for metastatic breast cancer: A meta-analysis on safety outcomes
    Rizzo, A.
    Rinaldi, L.
    Massafra, R.
    Cusmai, A.
    Guven, D. C.
    La Forgia, D.
    Latorre, A.
    Giotta, F.
    ANNALS OF ONCOLOGY, 2023, 34 : S356 - S356
  • [23] Multicenter Retrospective Cohort Study of the Sequential Use of the Antibody-Drug Conjugates (ADCs) Trastuzumab Deruxtecan (T-DXd) and Sacituzumab Govitecan (SG) in Patients With HER2-Low Metastatic Breast Cancer (MBC)
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2024, 22 (01)
  • [24] Multicenter retrospective cohort study of the sequential use of the antibody-drug conjugates (ADCs) trastuzumab deruxtecan (T-DXd) and sacituzumab govitecan (SG) in patients with HER2-low metastatic breast cancer (MBC)
    Huppert, Laura
    Mahtani, Reshma
    Fisch, Samantha
    Dempsey, Naomi
    Premji, Sarah
    Raimonde-Taylor, Angelina
    Jacob, Saya
    Quintal, Laura
    Chien, Jo
    Melisko, Michelle
    Sandoval-Leon, Ana
    Carcas, Lauren
    Ahluwalia, Manmeet
    Harpalani, Natasha
    Hoppenworth, Jenna
    Idossa, Dame
    Rao, Ruta
    Giridhar, Karthik
    Rugo, Hope
    CANCER RESEARCH, 2024, 84 (09)
  • [25] Multicenter retrospective cohort study of the sequential use of the antibody-drug conjugates (ADCs) trastuzumab deruxtecan (T-DXd) and sacituzumab govitecan (SG) in patients with HER2-low metastatic breast cancer (MBC)
    Laura A. Huppert
    Reshma Mahtani
    Samantha Fisch
    Naomi Dempsey
    Sarah Premji
    Angelina Raimonde
    Saya Jacob
    Laura Quintal
    Michelle Melisko
    Jo Chien
    Ana Sandoval
    Lauren Carcas
    Manmeet Ahluwalia
    Natasha Harpalani
    Jenna Hoppenworth
    Anne Blaes
    Kelly Blum
    Mi-Ok Kim
    Dame Idossa
    Ruta Rao
    Karthik V. Giridhar
    Hope S. Rugo
    npj Breast Cancer, 11 (1)
  • [26] The Real-World Clinical Outcomes of Heavily Pretreated HER2+and HER2-Low Metastatic Breast Cancer Patients Treated with Trastuzumab Deruxtecan at a Single Centre
    Lazaratos, Anna-Maria
    Dankner, Matthew
    Hamouda, Aalya
    Labidi, Soumaya
    Cohen, Victor
    Panasci, Lawrence
    Friedmann, Jennifer E.
    Patenaude, Francois
    Ferrario, Cristiano
    Basik, Mark
    Rose, April A. N.
    Fallah, Parvaneh
    CURRENT ONCOLOGY, 2025, 32 (01)
  • [27] Real-world clinical outcomes and toxicity in metastatic breast cancer patients treated with palbociclib and endocrine therapy
    Leticia Varella
    Akaolisa Samuel Eziokwu
    Xuefei Jia
    Megan Kruse
    Halle C. F. Moore
    George Thomas Budd
    Jame Abraham
    Alberto J. Montero
    Breast Cancer Research and Treatment, 2019, 176 : 429 - 434
  • [28] Real-world clinical outcomes and toxicity in metastatic breast cancer patients treated with palbociclib and endocrine therapy
    Varella, Leticia
    Eziokwu, Akaolisa Samuel
    Jia, Xuefei
    Kruse, Megan
    Moore, Halle C. F.
    Budd, George Thomas
    Abraham, Jame
    Montero, Alberto J.
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 176 (02) : 429 - 434
  • [29] Exposure-response analyses of sacituzumab govitecan efficacy and safety in patients with metastatic breast cancer
    Singh, Indrajeet
    Sathe, Abhishek
    Diderichsen, Paul
    Witjes, Han
    Van Schanke, Arne
    Maringwa, John
    Verret, Wendy
    Girish, Sandhya
    Othman, Ahmed
    CANCER RESEARCH, 2024, 84 (09)
  • [30] Sacituzumab govitecan-a new therapy for patients with triple-negative breast cancer
    Pogoda, Katarzyna
    Jagiello-Gruszfeld, Agnieszka
    Niwinska, Anna
    Nowecki, Zbigniew
    ONCOLOGY IN CLINICAL PRACTICE, 2023, 19 (01): : 43 - 49
12345